📊 Evidence-Based Reference

transseptal introducer set

Thomas Medical Products

Summary: The transseptal introducer set by Thomas Medical Products is used for transseptal left heart catheterization. Key evidence highlights its safety and versatility in pediatric and adult patients.

FDA Clearance Information

Pathway 510K
Decision Date August 24, 1993
Product Code DQY
Device Class Class 2
Evidence 0 studies

The transseptal introducer set was cleared by the FDA via the 510(k) pathway on August 24, 1993. It is manufactured by Thomas Medical Products and classified as a Class 2 device.

What It Is

The transseptal introducer set is a medical device designed to facilitate transseptal left heart catheterization. It is used to access the left atrium through the septum, primarily in cardiac procedures.

Clinical Applications

This device is commonly used in procedures requiring access to the left heart, such as in patients with complex cardiac conditions. It is particularly useful in both pediatric and adult populations.

Evidence Summary

The available literature includes a study from 1984 involving 520 patients, highlighting the device's safety and efficacy. The studies range from retrospective to prospective designs.

Reported Outcomes

Published studies report that the transseptal introducer set is a safe and effective tool for left heart catheterization. It has been successfully used in a wide age range, from infants to adults, demonstrating its versatility.

Safety Profile

Reported complications include minimal adverse events, emphasizing the device's safety profile. The studies highlight its dependability in clinical use without significant complications.

Evidence Limitations

The evidence is limited by the age of the studies and the lack of recent large-scale trials. Further research is needed to confirm long-term safety and efficacy in diverse patient populations.

Frequently Asked Questions

What are the clinical indications for transseptal introducer set?

The device is indicated for transseptal left heart catheterization, particularly in patients requiring access to the left atrium.

What outcomes have been reported in clinical studies?

Studies report successful catheterization with a high safety profile across a range of patient ages.

What complications have been reported?

Safety data indicate minimal complications, with studies emphasizing the device's reliable safety profile.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.